Kira Pharmaceuticals’ $53.5 Million Series B+ Financing

Brown Rudnick LLP advised RA Capital Management on the deal. Kira Pharmaceuticals announced its $53.5-million Series B+ financing to advance the LOGIC drug discovery platform. Kira…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here